(Q43918948)

28 November 2017

Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma (English)

1 reference

28 November 2017

Pavone V

1

1 reference

28 November 2017

Gaudio F

2

1 reference

28 November 2017

Guarini A

3

1 reference

28 November 2017

Perrone T

4

1 reference

28 November 2017

Zonno A

5

1 reference

28 November 2017

Curci P

6

1 reference

28 November 2017

Liso V

7

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Bone Marrow Transplantation

28 November 2017

1 reference

28 November 2017

29

1 reference

28 November 2017

4

1 reference

28 November 2017

285-290

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703364

28 November 2017

0 references

cites work

Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphom

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

Effect of alternating combination chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, cisplatin, and etoposide for small cell lung cancer on hematopoietic progenitors in the peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

The role of cytokines and adhesion molecules for mobilization of peripheral blood stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

The role of stem cell factor in mobilization of peripheral blood progenitor cells: synergy with G-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

Peripheral blood progenitor cell mobilization in patients with primary refractory lymphoma or at first relapse: comparison with patients at diagnosis and impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte-colony-stimulating factor: implications for yield of hematopoietic progenitor cell collections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

The importance of CD34+/CD33− cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

Regulation of hematopoietic progenitor cell migration, mobilization and homing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

Expression of adhesion molecules on human hematopoietic progenitor cells at different maturational stages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

Effect of rhG-CSF on the mobilization of CD38 and HLA-DR subfractions of CD34+ peripheral blood progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

Progenitor cell yields are frequently poor in patients with histologically indolent lymphomas especially when mobilized within 6 months of previous chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

The absolute number of circulating CD34+ cells as the best predictor of peripheral hematopoietic stem cell yield

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703364

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703364

1 reference

Dimensions Publication ID

28 November 2017

0 references

1 reference